Indica Labs: AI and Digital Pathology in Personalized Medicine: The Past, Present, and Future of Breast Cancer Care
recent articles
Hørsholm, Denmark, May 5, 2015: Visiopharm, the leader in image analysis for diagnostic digital pathology, announces today the closing of a private round of financing with NorthCap Partners. The investment amount is undisclosed. This...
Visiopharm releases today an updated, easier to navigate website and rebranding of our popular software solutions. The website introduces three main product sections – BIOtopix™, STEREOtopix™, and the new cancer focused...
Presented by Ramu Sheshadri, Product Manager, SaaS Solutions Leica Biosystems Date: 07 May 2015 - Time: 9:00 AM CST Register Now! Learn how Aperio ePathAccess from Leica Biosystems can improve pathology secondary case...
Register now for a QualityStar Webinar by Dr. Jared Schwartz Date: Thursday June 4 Time: 11:00...
The NPR (5/1, Haelle) “Shots” blog reports that yesterday, the American College of Physicians released guidelines “that aim to reduce unnecessary” cervical cancer “screening. They say that no women should be getting annual Pap...
Information Technology in Digital Pathology The future paradigm of Pathology will be Digital. Instead of conventional microscopy, a pathologist will perform diagnosis through interaction with images on computer screens and performing...
